首页    期刊浏览 2024年11月28日 星期四
登录注册

文章基本信息

  • 标题:The Roles of EP4 Prostanoid Receptors in Cancer Malignancy Signaling
  • 本地全文:下载
  • 作者:Hiromichi Fujino
  • 期刊名称:Biological and Pharmaceutical Bulletin
  • 印刷版ISSN:0918-6158
  • 电子版ISSN:1347-5215
  • 出版年度:2016
  • 卷号:39
  • 期号:2
  • 页码:149-155
  • DOI:10.1248/bpb.b15-00840
  • 出版社:The Pharmaceutical Society of Japan
  • 摘要:The lipid mediator prostanoids consist of prostaglandins and thromboxanes, and are synthesized from arachidonic acid by the action of cyclooxygenase. There are five major prostanoids, including prostaglandin E2 (PGE2), and they are involved in a variety of biological responses such as inflammation, allergy, parturition, and tumorigenesis. These prostanoids exert their effects via activation of their cognate G protein coupled receptors, e.g ., E-type prostanoid (EP) receptors for PGE2. The EP receptors are composed of four subtypes, namely EP1 to EP4. Here, breakthroughs in the last dozen years of research are introduced, with a special focus on some important findings of EP4 receptor-mediated signaling and the signaling associated with cancer development, particularly in colon cancer.
国家哲学社会科学文献中心版权所有